A new method allows scientists at ETH Zurich and IBM to fabricate artificial molecules out of different types of microspheres. The researchers would like to one day use such tiny objects in micro-robots, for photonics and basic biochemical research.
Scientists at ETH Zurich and IBM Research Zurich have developed a new technique that enables for the first time the manufacture of complexly structured tiny objects joining together microspheres. The objects have a size of just a few micrometres and are produced in a modular fashion, making it possible to program their design in such a way that each component exhibits different physical properties. After fabrication, it is also very simple to bring the micro-objects into solution.
This makes the new technique substantially different from micro 3D printing technology. With most of today’s micro 3D printing technologies, objects can only be manufactured if they consist of a single material, have a uniform structure and are attached to a surface during production.
To prepare the micro-objects, the ETH and IBM researchers use tiny spheres made from a polymer or silica as their building blocks, each with a diameter of approximately one micrometre and different physical properties. The scientists are able to control the particles and arrange them in the geometry and sequence they like.
The structures that are formed occupy an interesting niche in the size scale: they are much larger than your typical chemical or biochemical molecules, but much smaller than typical objects in the macroscopic world. “Depending on the perspective, it’s possible to speak of giant molecules or micro-objects,” says Lucio Isa, Professor for Interfaces, Soft matter and Assembly at ETH Zurich. He headed the research project together with Heiko Wolf, a scientist at IBM Research. “So far, no scientist has succeeded in fully controlling the sequence of individual components when producing artificial molecules on the micro scale,” says Isa.
Diverse range of applications
With the new method, it is possible to manufacture micro-objects with precisely defined magnetic, non-magnetic and differently charged areas. Currently, the scientists can create small rods of varying lengths and composition, tiny triangles and basic three-dimensional objects. But the researchers are keen to develop the technique further. As possible future applications, they are considering self-propelled micro-carriers that move in an external electric field thanks to their sophisticated geometry and material composition.
Other possibilities include micro-mixers for lab-on-a-chip applications or, in the distant future, even micro-robots for biomedical applications which can grab, transport and release other specific micro-objects. Additionally, the researchers could design their artificial molecules so that they interact with each other and assemble together independently into larger ‘superstructures’. This would be for instance relevant for photonics (light-based signal processing). “Customised micro-structures are required in photonics. These could one day be manufactured with our components,” says Isa.
Production with micro-templates
To manufacture a large number of identical micro-objects at the same time, the scientists use polymer templates with indentations engraved in the form of the object they want to produce. The researchers developed a method that allows them to deposit one tiny sphere at a time during each step of the procedure. They can build up larger objects sequentially, choosing the type of sphere for each step. At the end, they connect the tiny spheres together by briefly heating them.
Learn more: Artificial molecules
The Latest on: Artificial molecules
via Google News
The Latest on: Artificial molecules
- How chemists are building molecular assembly lineson May 18, 2021 at 4:30 am
Four huge robot arms surround the gleaming metal shell of what will soon be a top-of-the-range automobile. They jerk into life, attaching the bonnet, the wing mirrors, and other panels. It's the kind ...
- Iktos, Kadmon partner to use AI for new drug designon May 18, 2021 at 1:01 am
Iktos, a company specializing in Artificial Intelligence (AI) for new drug design, today announced that it has entered into a Research Collaboration Agreement with Kadmon, a clinical-stage ...
- Iktos Announces Collaboration with Kadmon to Use AI for New Drug Designon May 18, 2021 at 12:47 am
Iktos, a company specializing in Artificial Intelligence for new drug design, today announced that it has entered into a Research Collaboration Agreement with Kadmon, a clinical-stage ...
- Mechanics of the infinitely small: NanoGear, towards a molecular gearon May 17, 2021 at 1:29 pm
Gears and mechanical transmissions are at home in the Emilia-Romagna region, the Motor Valley of northern Italy. A team of researchers from the University of Bologna and the Institute for Organic ...
- 10 Reasons You Will Never Want to Drink Diet Soda Againon May 17, 2021 at 1:00 pm
Daily consumption of diet soda was linked to a 67% higher risk of developing type 2 diabetes, which nearly 10% of Americans have. Diabetes was the seventh leading cause of death in the United States ...
- Harvesting Light Like Nature Does: Synthesizing a New Class of Bio-Inspired, Light-Capturing Nanomaterialson May 17, 2021 at 12:57 pm
Inspired by nature, researchers at Pacific Northwest National Laboratory (PNNL), along with collaborators from Washington State University, created a novel material capable of capturing light energy.
- Micrometre-size molecular modelling kit shows real chemical reactionson May 17, 2021 at 4:21 am
Scientists have found a way to build micrometre-size model molecules using 'patchy particles'. This allows for a much more direct study of molecular dynamics.
- Exscientia’s third AI-discovered molecule to enter trialson May 13, 2021 at 7:00 am
Exscientia’s AI-designed DSP-0038 is about to enter Phase I trials in the US for the treatment of Alzheimer’s disease psychosis. Oxford-based pharmatech company Exscientia has announced that its ...
- Exscientia Announces Second Molecule Created Using AI From Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trialon May 13, 2021 at 4:30 am
Exscientia Ltd. (Headquarters: Oxford, UK; CEO: Andrew Hopkins) is pleased to acknowledge that Sumitomo Dainippon Pharma Co., Ltd. (Head office: Osaka ...
- Under Pressure: Manipulating Protein-mimicking Molecules with Hydrostatic Pressureon May 12, 2021 at 7:05 pm
Stimulus-responsive supramolecular structures have emerged as an alternative to conventional ones, owing to their applications in sensing, drug delivery, and switchable memory systems. Now, ...
via Bing News